Imagine a world where parents could handpick their child’s traits—taller, smarter, healthier. It sounds like science fiction, but it’s already being marketed as a reality. But here’s where it gets controversial: genetic tests claiming to predict which IVF embryo will grow into the 'best' child are flooding the market, promising a future that may not be as rosy as it seems. Let’s dive into why this trend is raising more questions than answers.
Prospective parents are increasingly being lured by companies offering genetic tests that claim to predict complex traits like height, IQ, or even the risk of diseases such as heart disease or Alzheimer’s. These tests generate something called ‘polygenic risk scores’ for embryos, supposedly helping parents choose the ‘optimal’ one for implantation. And this is the part most people miss: while the promise sounds revolutionary, the science behind it is far from reliable.
Here’s the catch: these tests aren’t like traditional genetic screenings for single-gene disorders like cystic fibrosis. Instead, they attempt to predict traits influenced by thousands of genes interacting in ways we barely understand. The benefits? Minimal at best—maybe a slight IQ boost or a few extra centimeters in height. But the risks? Very real, both for individuals and society.
Our research group scrutinized these polygenic risk scores using the same rigorous standards applied to any medical screening test. The results were eye-opening. Predicting late-onset diseases is virtually impossible since the outcomes won’t be known for decades. Even for traits like height or IQ, mathematical models suggest the benefits are negligible—a few IQ points or 1–3 centimeters in height. Bold claim: Is a 3cm height difference really worth the ethical and practical dilemmas these tests introduce?
Here’s another layer to consider: the data used to create these scores comes from people in their 50s and 60s who grew up in vastly different environments. Think no smartphones, less processed food, and lower pollution levels. Their genetic patterns may not apply to today’s—or tomorrow’s—world. Traits and diseases are shaped by lifelong interactions between genes and the environment, making these predictions even more uncertain.
Take IQ, for example. Early childhood education, nutrition, and socioeconomic factors play a massive role in cognitive development. Choosing an embryo based solely on a genetic score while ignoring these influences is like predicting a plant’s growth from its seed without considering soil, sunlight, or water. Thought-provoking question: Are we oversimplifying human potential by reducing it to a genetic score?
There’s also the issue of pleiotropy—one gene can influence multiple traits. Selecting for higher IQ might inadvertently increase the risk of other conditions, like bipolar disorder. It’s a genetic gamble with unpredictable outcomes.
Ethically, the waters are murky. In Australia, guidelines recommend genetic testing to avoid serious inherited conditions, but polygenic risk scores operate in a regulatory grey zone. They’re not diagnoses; they’re predictions of future risks. Yet, parents are sending samples overseas for analysis, often without fully understanding the limitations.
Controversial interpretation: Could this trend lead to a new form of eugenics, where embryos are selected based on perceived ‘desirable’ traits? The debate is far from settled.
Then there’s decision paralysis. Imagine receiving risk scores for multiple embryos across dozens of traits and conditions. How do you choose? It’s not just a medical decision—it’s a moral one, fraught with uncertainty and second-guessing. Worse, couples undergoing IVF solely for these tests may actually reduce their chances of a healthy baby due to the risks associated with the procedure itself.
Final thought-provoking question: Are we chasing a genetic mirage at the expense of proven factors like lifestyle and environment? Let’s keep the conversation going—what do you think? Share your thoughts in the comments below.
